Show simple item record

dc.contributor.authorAras, Yavuz
dc.contributor.authorAktas, Esin
dc.contributor.authorSabanci, Akin
dc.contributor.authorAlpman, Vehbi
dc.contributor.authorBilir, Ayhan
dc.contributor.authorErguven, Mine
dc.contributor.authorYazihan, Nuray
dc.contributor.authorErmis, Ezgi
dc.date.accessioned2021-03-05T19:24:44Z
dc.date.available2021-03-05T19:24:44Z
dc.identifier.citationErguven M., Bilir A., Yazihan N., Ermis E., Sabanci A., Aktas E., Aras Y., Alpman V., "Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine", CANCER CELL INTERNATIONAL, cilt.11, 2011
dc.identifier.issn1475-2867
dc.identifier.othervv_1032021
dc.identifier.otherav_cf2c9204-f763-44de-9139-4bcbd6dbf35a
dc.identifier.urihttp://hdl.handle.net/20.500.12627/137001
dc.identifier.urihttps://doi.org/10.1186/1475-2867-11-18
dc.description.abstractBackground: Glioblastoma (GBM) develops resistance to the advances in chemotherapy leading to poor prognosis and life quality. Consequently, new treatment modalities are needed. Our aims were to investigate the effects of combined noscapine (NOS) and imatinib mesylate (IM) on human GBM in vitro and the role of midkine (MK) in this new combination treatment.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleDecreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine
dc.typeMakale
dc.relation.journalCANCER CELL INTERNATIONAL
dc.contributor.departmentİstanbul Yeni Yüzyıl Üniversitesi , ,
dc.identifier.volume11
dc.contributor.firstauthorID71412


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record